- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Novogen Ltd+ Add to Watchlist
NVGN:US2.8982 USD 0.0482 1.69%
As of 20:10:00 ET on 10/01/2014.
Company Profile for Novogen Ltd (NVGN)
Novogen Limited is a medical services company which develops and markets pharmaceutical products in Australia. The Company conducts clinical trials on medications which promote the prevention and treatment of common cancers and the reversal of immune depression. The Company also develops dietary supplements, hormonal imbalance drugs, anti-inflammatory and cardiovascular drugs.
Key Executives for Novogen Ltd (NVGN)
|Graham Edmund KellyChairman/CEO/Founder||David BrownChief Scientific Officer|
|Justine StehnDir:ATM Program||Stephen PalmerDir:Degenerative Disease Program|
|Christine BruceFinancial Controller||Lionel MateoSecretary|